Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cobimetinib and Irinotecan Liposome.

Hospital pharmacy·2024
Same author

Pertuzumab, Trastuzumab, and Docetaxel for HER2-Positive Breast Cancer.

Hospital pharmacy·2024
Same author

Drug Monographs: Trabectedin and Trifluridine-Tipiracil.

Hospital pharmacy·2024
Same author

Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases.

Hospital pharmacy·2017
Same author

Drug Monographs: Avelumab and Ribociclib.

Hospital pharmacy·2017
Same author

Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.

Hospital pharmacy·2017

Related Experiment Video

Updated: Apr 3, 2026

Evaluating In Vitro DNA Damage Using Comet Assay
10:43

Evaluating In Vitro DNA Damage Using Comet Assay

Published on: October 11, 2017

40.2K

Nivolumab and Olaparib.

Dominic A Solimando, J Aubrey Waddell

    Hospital Pharmacy
    |September 26, 2015
    PubMed
    Summary

    Pharmacists must understand complex cancer chemotherapy regimens and toxic agents. This review covers preparation, dispensing, and administration of antineoplastic therapies and related agents for treating malignant diseases.

    Area of Science:

    • Oncology Pharmacy
    • Chemotherapy Administration

    Background:

    • Cancer chemotherapy involves complex regimens and highly toxic agents.
    • Pharmacists play a crucial role in managing antineoplastic therapy.

    Purpose of the Study:

    • To review key issues in the preparation, dispensing, and administration of antineoplastic therapy.
    • To discuss commercially available and investigational agents used in treating malignant diseases.

    Main Methods:

    • Literature review and expert knowledge compilation.
    • Discussion of practical aspects of chemotherapy management.

    Main Results:

    • Identification of complexities in chemotherapy regimens.
    • Overview of various antineoplastic agents and their administration challenges.

    More Related Videos

    Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
    07:04

    Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

    Published on: May 2, 2025

    1.3K
    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
    04:07

    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

    Published on: February 24, 2023

    2.4K

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Evaluating In Vitro DNA Damage Using Comet Assay
    10:43

    Evaluating In Vitro DNA Damage Using Comet Assay

    Published on: October 11, 2017

    40.2K
    Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
    07:04

    Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

    Published on: May 2, 2025

    1.3K
    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
    04:07

    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

    Published on: February 24, 2023

    2.4K

    Conclusions:

    • Pharmacists require specialized knowledge for safe and effective cancer chemotherapy.
    • Continuous education on antineoplastic agents and protocols is essential for oncology pharmacists.